论文部分内容阅读
目的探讨米索配伍雷夫诺尔在１０－１４周妊娠流产中的作用。方法对７２例１０－１４周妊娠的正常孕妇有流产指征者，行雷夫诺尔１００ｇ羊膜腔外注入术后１２小时，４２例口报米索３００μｇ，２小时后追加３００μｇ，观察宫缩及宫颈的变化，据宫缩情况再追加米索，４８小时内最大量达１８００μｇ。结果服用米索组宫缩出现早，产程短，平均２６小时１６分，与对照组（３０例）比，有极显著性差异（Ｐ＜０．００１），流产总成功率９２．８６％。完全流产率９０．４８％。结论对１０－１４周妊娠者，应用米索配伍雷夫诺尔羊膜腔外注入流产是目前有效、方便、价廉、副反应少的药物流产方法。
Objective To investigate the effect of misoprostol and rifamole on abortion of 10-14 weeks. Methods 72 cases of 10-14 weeks pregnant women with normal indications for abortion, Levonorr 100g amniotic fluid injection 12 hours after surgery, 42 cases of oral 300ml misoprostol, 2 hours after the addition of 300μg, observed contractions and Changes in the cervix, according to contractions and then add misoprostol, up to 1800μg within 48 hours. Results The contractions of misoprostol in misoprostol appeared early and the duration of labor was short, with an average of 26 hours and 16 minutes. There was a significant difference (P <0.001) between the control and the control group (30 cases). The total success rate of abortion was 92.86%. Complete abortion rate of 90.48%. Conclusion 10-14 weeks of pregnancy, the application of misoprostol levonor amniotic fluid injection into the abortion is the current effective, convenient, inexpensive, less side effects of drug abortion.